Inhaled corticosteroids prescriptions increased in the ED for recurrent asthma exacerbations by automated electronic reminders in the ED

Adam Farmer, Lucia Mirea, Jodi Carter, Matthew A Rank, Blake Bulloch, Vinay Vaidya, Rupali Drewek

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: The objective of this study was to evaluate the impact of an electronic alert on the prescription rate of inhaled corticosteroids (ICS) by ED providers for poorly controlled persistent asthmatic children. Methods: Study subjects included asthmatic patients age 4–18 presenting to the ED at Phenix Children’s Hospital between February 9, 2018 and December 4, 2018, with a history of at least two previous ED visits for acute exacerbation of asthma within 365 days, no active ICS prescription within 90 days, and free from developmental delay, bronchopulmonary dysplasia due to prematurity, cystic fibrosis, sickle cell disease, and/or interstitial ling disease. Patients meeting these criteria triggered an electronic alert prompting the medical provider to prescribe ICS or indicate reason for not prescribing. Instruction on the alert was provided to ED attending physicians and residents by email and through several educational sessions held prior to the implementation. Results: Among 62 patients without prior ICS who were discharged home from the ED, ICS was prescribed for 48 (77%). No statistically significant differences were detected in baseline characteristics between patients discharged home from the ED with and without ICS prescription. While ICS was prescribed by a larger proportion of physicians (56%) compared to residents (42%), statistical significance was not reached. For the 14 (33%) patients who were discharged home without ICS, no reason was provided to indicate why ICS were not prescribed. Conclusion: An electronic alert incorporated into the ED workflow to populate a discharge order set is effective to initiate asthma controller medication for poorly controlled pediatric patients. Additional data describing reasons for not prescribing ICS can further refine recommendations for ICS prescriptions, and provide a comprehensive strategy to support clinical decision for pediatric asthma control in acute care settings.

Original languageEnglish (US)
JournalJournal of Asthma
DOIs
StatePublished - Jan 1 2019

Fingerprint

Prescriptions
Adrenal Cortex Hormones
Asthma
Clinical Decision Support Systems
Pediatrics
Physicians
Bronchopulmonary Dysplasia
Workflow
Sickle Cell Anemia
Cystic Fibrosis

Keywords

  • control/management
  • education
  • management/control
  • Prevention
  • treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Inhaled corticosteroids prescriptions increased in the ED for recurrent asthma exacerbations by automated electronic reminders in the ED. / Farmer, Adam; Mirea, Lucia; Carter, Jodi; Rank, Matthew A; Bulloch, Blake; Vaidya, Vinay; Drewek, Rupali.

In: Journal of Asthma, 01.01.2019.

Research output: Contribution to journalArticle

@article{64a15d2c524e4bd7b2df1faa2dc38f9d,
title = "Inhaled corticosteroids prescriptions increased in the ED for recurrent asthma exacerbations by automated electronic reminders in the ED",
abstract = "Objective: The objective of this study was to evaluate the impact of an electronic alert on the prescription rate of inhaled corticosteroids (ICS) by ED providers for poorly controlled persistent asthmatic children. Methods: Study subjects included asthmatic patients age 4–18 presenting to the ED at Phenix Children’s Hospital between February 9, 2018 and December 4, 2018, with a history of at least two previous ED visits for acute exacerbation of asthma within 365 days, no active ICS prescription within 90 days, and free from developmental delay, bronchopulmonary dysplasia due to prematurity, cystic fibrosis, sickle cell disease, and/or interstitial ling disease. Patients meeting these criteria triggered an electronic alert prompting the medical provider to prescribe ICS or indicate reason for not prescribing. Instruction on the alert was provided to ED attending physicians and residents by email and through several educational sessions held prior to the implementation. Results: Among 62 patients without prior ICS who were discharged home from the ED, ICS was prescribed for 48 (77{\%}). No statistically significant differences were detected in baseline characteristics between patients discharged home from the ED with and without ICS prescription. While ICS was prescribed by a larger proportion of physicians (56{\%}) compared to residents (42{\%}), statistical significance was not reached. For the 14 (33{\%}) patients who were discharged home without ICS, no reason was provided to indicate why ICS were not prescribed. Conclusion: An electronic alert incorporated into the ED workflow to populate a discharge order set is effective to initiate asthma controller medication for poorly controlled pediatric patients. Additional data describing reasons for not prescribing ICS can further refine recommendations for ICS prescriptions, and provide a comprehensive strategy to support clinical decision for pediatric asthma control in acute care settings.",
keywords = "control/management, education, management/control, Prevention, treatment",
author = "Adam Farmer and Lucia Mirea and Jodi Carter and Rank, {Matthew A} and Blake Bulloch and Vinay Vaidya and Rupali Drewek",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/02770903.2019.1635152",
language = "English (US)",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Inhaled corticosteroids prescriptions increased in the ED for recurrent asthma exacerbations by automated electronic reminders in the ED

AU - Farmer, Adam

AU - Mirea, Lucia

AU - Carter, Jodi

AU - Rank, Matthew A

AU - Bulloch, Blake

AU - Vaidya, Vinay

AU - Drewek, Rupali

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: The objective of this study was to evaluate the impact of an electronic alert on the prescription rate of inhaled corticosteroids (ICS) by ED providers for poorly controlled persistent asthmatic children. Methods: Study subjects included asthmatic patients age 4–18 presenting to the ED at Phenix Children’s Hospital between February 9, 2018 and December 4, 2018, with a history of at least two previous ED visits for acute exacerbation of asthma within 365 days, no active ICS prescription within 90 days, and free from developmental delay, bronchopulmonary dysplasia due to prematurity, cystic fibrosis, sickle cell disease, and/or interstitial ling disease. Patients meeting these criteria triggered an electronic alert prompting the medical provider to prescribe ICS or indicate reason for not prescribing. Instruction on the alert was provided to ED attending physicians and residents by email and through several educational sessions held prior to the implementation. Results: Among 62 patients without prior ICS who were discharged home from the ED, ICS was prescribed for 48 (77%). No statistically significant differences were detected in baseline characteristics between patients discharged home from the ED with and without ICS prescription. While ICS was prescribed by a larger proportion of physicians (56%) compared to residents (42%), statistical significance was not reached. For the 14 (33%) patients who were discharged home without ICS, no reason was provided to indicate why ICS were not prescribed. Conclusion: An electronic alert incorporated into the ED workflow to populate a discharge order set is effective to initiate asthma controller medication for poorly controlled pediatric patients. Additional data describing reasons for not prescribing ICS can further refine recommendations for ICS prescriptions, and provide a comprehensive strategy to support clinical decision for pediatric asthma control in acute care settings.

AB - Objective: The objective of this study was to evaluate the impact of an electronic alert on the prescription rate of inhaled corticosteroids (ICS) by ED providers for poorly controlled persistent asthmatic children. Methods: Study subjects included asthmatic patients age 4–18 presenting to the ED at Phenix Children’s Hospital between February 9, 2018 and December 4, 2018, with a history of at least two previous ED visits for acute exacerbation of asthma within 365 days, no active ICS prescription within 90 days, and free from developmental delay, bronchopulmonary dysplasia due to prematurity, cystic fibrosis, sickle cell disease, and/or interstitial ling disease. Patients meeting these criteria triggered an electronic alert prompting the medical provider to prescribe ICS or indicate reason for not prescribing. Instruction on the alert was provided to ED attending physicians and residents by email and through several educational sessions held prior to the implementation. Results: Among 62 patients without prior ICS who were discharged home from the ED, ICS was prescribed for 48 (77%). No statistically significant differences were detected in baseline characteristics between patients discharged home from the ED with and without ICS prescription. While ICS was prescribed by a larger proportion of physicians (56%) compared to residents (42%), statistical significance was not reached. For the 14 (33%) patients who were discharged home without ICS, no reason was provided to indicate why ICS were not prescribed. Conclusion: An electronic alert incorporated into the ED workflow to populate a discharge order set is effective to initiate asthma controller medication for poorly controlled pediatric patients. Additional data describing reasons for not prescribing ICS can further refine recommendations for ICS prescriptions, and provide a comprehensive strategy to support clinical decision for pediatric asthma control in acute care settings.

KW - control/management

KW - education

KW - management/control

KW - Prevention

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85068873480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068873480&partnerID=8YFLogxK

U2 - 10.1080/02770903.2019.1635152

DO - 10.1080/02770903.2019.1635152

M3 - Article

C2 - 31226000

AN - SCOPUS:85068873480

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

ER -